Apoptosis and increased expression of Fas ligand after uniocular anterior chamber (AC) inoculation of HSV-1

References

• Nagata S, Golstein P. The Fas Death Factor. Science. 1995;267:1449–1456.
   PubMed Web of Science ®Google Scholar
• Miyawaki T, Uehara T, Nibu R, Tsuji T, Yachie A, Yonehara S, Taniguchi N. Differential expression of apoptosis-related Fas antigen on lymphocyte subpopulations in human peripheral blood. J ImmunoL 1992;149:3753–3758.
   Google Scholar
• Watanabe-Fukunaga R, Brannan CI, Coppeland NG, Jenkins NA, Negata S. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature. 1992;356:314–317.
   Google Scholar
• Suda T, Okazaki T, Naito Y, Yokota T, Arai N, Ozaki S, Nakao K, Nagata S. Expression of the Fas ligand in cells of T cell lineage. J ImmunoL 1995;154:3806–3813.
   PubMed Web of Science ®Google Scholar
• Suda T, Nagata S. Purification and characterization of the Fas-ligand that induces apoptosis. J Exp Med. 1994;179: 873–879.
   PubMed Web of Science ®Google Scholar
• Hueber A-0, Zörnig M, Lyon D, Suda T, Nagata S, Evan GI. Requirement for the CD95 receptor-ligand pathway in c-Myc-induced apoptosis. Science. 1997;278: 1305–1309.
   Google Scholar
• Cleveland JL, Ihle JN. Contenders in FasL/TNF death sig-naling. Cell. 1995;81:479–482.
   PubMed Web of Science ®Google Scholar
• French, LE, Hahne M, Viard I, Radlgruber G, Zanone R, Becker K, Muller C, Tschopp J. Fas and Fas ligand in embryos and adult mice: Ligand expression in several immune-privileged tissues and coexpression in adult tissues characterized by apoptotic cell turnover. J Cell Biol. 1996;133:335–343.
   Google Scholar
• Suda, T, Takahashi T, Golstein P, Nagata S. Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell. 1993;75:1169–1178.
   Google Scholar
• Mori T, Xu JP, Mori E, Sato E, Saito S, Guo MW. Expres-sion of Fas-Fas ligand system associated with atresia through apoptosis in murine ovary. Horm Res. 1997; 48(Suppl 3):11–19.
   Google Scholar
• Shen, DF, Matteson DM, Tuaillon N, Suedekum BK, Buggage RR, Chan CC. Involvement of apoptosis and interferon in murine toxoplasmosis. Invest Ophthalmol Vis Sci. 2001;42:2031–2036.
   PubMed Web of Science ®Google Scholar
• Takahashi T, Tanaka M, Brannan CI, Jenkins NA, Copeland NG, Suda T, Nagata S. Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand. Cell. 1994;76:969–976.
   Google Scholar
• Griffith, TS, Brunner T, Fletcher SM, Green DR, Ferguson TA. Fas ligand-induced apoptosis as a mechanism of immune privilege. Science. 1995;270: 1189–1192.
   PubMed Web of Science ®Google Scholar
• Kaplan HJ, Leibole MA, Tezel T, Ferguson TA. Fas ligand (CD95 ligand) controls angiogenesis beneath the retina. Nat Med. 1999;5:292–297.
   PubMed Web of Science ®Google Scholar
• Chen JJ, Sun Y, Nabel GJ. Regulation of the proinflamma-tory effects of Fas ligand (CD95L). Science. 1999; 282:1714–1718.
   Google Scholar
• Wilson SE, Li Q, Weng J, Barry-Lane PA, Jester JV, Liang Q, Wordinger RJ. The Fas-Fas Ligand system and other modulators of apoptosis in the cornea. Invest Ophthalmol Vis Sci. 1996;37:1582–1592.
   PubMedGoogle Scholar
• Vann VR, Atherton SS. Neural spread of herpes simplex virus after anterior chamber inoculation. Invest Ophthalmol Vis Sci. 1991;32:2462–2472.
   PubMed Web of Science ®Google Scholar
• Cousins SW, Gonzalez A, Atherton SS. Herpes simplex retinitis in the mouse: Clinicopathologic correlations. Invest Ophthalmol Vis Sci. 1989;30:1485–1494.
   PubMed Web of Science ®Google Scholar
• Azumi A, Atherton SS. Sparing of the ipsilateral retina afteranterior chamber inoculation of HSV-1: Requirement for either CD4+ or CD8+ T cells. Invest Ophthamol Vis Sci. 1994;35:3251–3259.
   PubMed Web of Science ®Google Scholar
• Whittum JA, McCulley JP, Niederkorn JY, Streilein JW Ocular disease induced in mice by anterior chamber inoc-ulation of herpes simplex virus. Invest Ophthalmol Vis Sci. 1984:25:1065–1073.
   PubMed Web of Science ®Google Scholar
• Tanigawa M, Bigger JE, Kanter MY, Atherton SS. Natural killer cells prevent direct anterior-to-posterior spread of herpes simplex virus typel in the eye. Invest Ophthalmol Vis Sci. 2000;41:132–137.
   PubMed Web of Science ®Google Scholar
• Zhao M, Azumi A, Atherton SS. T Lymphocyte infiltration in the brain following anterior chamber inoculation of HSV- 1. J NeuroimmunoL 1995;58: 11–19.
   Google Scholar
• Streilein JW, Atherton SS, Vann V A critical role for ACAID in the distinctive pattern of retinitis that follows anterior chamber inoculation of HSV-1. Curr Eye Res. 1987;6:127–131.
   PubMed Web of Science ®Google Scholar
• Griffith TS, Ferguson TA. The role of Fas-induced apopto-sis in immune privilege. Immunol Today. 1997;18:240–244.
   PubMedGoogle Scholar
• Griffith TS, Yu X, Herndon JM, Green DR, Ferguson TA. CD95-induced apoptosis of lymphocytes in an immune privileged site induces immunological tolerance. Immunity 1996;5: 7–16.
   Google Scholar
• Green DR, Ferguson TA. The role of Fas ligand in immune privilege. Nat Rev Mol Cell Biol. 2001;2:917–924.
   PubMed Web of Science ®Google Scholar
• Romashkova JA, Makarov SS. NF-KB is a target of AKT in anti-apoptotic PDGF signaling. Nature. 1999;401: 86–90.
   PubMed Web of Science ®Google Scholar
• Devitt A, Moffatt OD, Raykundalia C, Capra JD, Simmons DL, Gregory CD. Human CD14 mediates recognition and phagocytosis of apoptotic cells. Nature. 1998;392:505–509.
   PubMed Web of Science ®Google Scholar
• Perng GC, Jones C, Ciacci-Zanella J, Stone M, Henderson G, Yukht A, Slanina SM, Hofman FM, Ghiasi H, Nesburn AB, Wechsler SL. Virus-induced neuronal apoptosisblocked by Herpes simplex virus latency-associated tran-script. Nature. 2000;287:1500–1503.
   Google Scholar
• Nguyen QD, Uy HS, Merchant A, Madina CA, Baltatzis S, Zhao T, Zhao ZS, Cantor H, Foster S. Effect of Fas ligand deficiency in resistance of C57BL/6 mice to HSV-1 keratitis and chorioretinitis. Invest Ophthalmol Vis Sci. 2001;42: 2505–2509.
   Google Scholar
• Villunger A, Egle A, Kos M, Hartmann BL, Geley S, Kofler R, Greil R. Drug-induced apoptosis is associated with enhanced Fas (Apo-1/CD95) ligand expression but occurs independently of Fas (Apo-1/CD95) signaling in human T-acute lymphatic leukemia cells. Cancer Res. 1997;57: 3331–3334.
   Google Scholar
• Couillard M, Guillaume R, Tanji N, D'Agati V, Trudel M. c-myc-induced apoptosis in polycystic kidney disease is independent of FasL/Fas interaction. Cancer Res. 2002;62: 2210–2214.
   Google Scholar
• Hanke J. Apoptosis in cultured rat islets of langerhans and occurrence of Bc1-2, Bak, Bax, Fas and Fas ligand. Cells Tissues Organs. 2001;169:113–124.
   Google Scholar
• Jones DT, Ganeshaguru K, Virchis AE, Folarin NI, Lowdell MW, Mehta AB, Prentice HG, Hoffbrand AV, Wickremasinghe RG. Caspase 8 activation independent of Fas (CD95/AP0-1) signaling may mediate killing of B-chronic lymphocytic leukemia cells by cytotoxic drugs or gamma radiation. Blood. 2001;98: 2800–2807.
   Google Scholar
• Zhou Z, Sun X, Kang YJ. Ethanol-induced apoptosis in mouse liver: Fas- and cytochrome c-mediated caspase-3 activation pathway. Am J PathoL 2001;159: 329–338.
   Google Scholar
• Tesarik J, Martinez F, Rienzi L, Iacobelli M, Ubaldi F, Mendoza C, Greco E. In vitro effects of FSH and testos-terone withdrawal on caspase activation and types of human seminiferous epithelium. Hum Rep rod. 2002 ;17: 1811–1819.
   Google Scholar
• Itoh N, Tsujimoto Y, Nagata S. Effect of bc1-2 on Fas antigen-mediated cell death. J ImmunoL 1993;151: 621–627.
   Google Scholar
• Villunger A, O'Reilly LA, Holler N, Adams J, Strasser A. Fas ligand, Bc1-2, granulocyte colony-stimulating factor, and p38 mitogen-activated protein kinase: Regulators of distinct cell death and survival pathway in granulocytes. J Exp Med. 2000;192:647–657.
   PubMed Web of Science ®Google Scholar